| abstract |
The present disclosure generally provides hemostasis comprising polysaccharide-based polymers, such as amylopectin, amylose, dextrin, maltodextrin and icodextrin, as well as modified forms thereof, that are cross-linked with a cross-linking agent that are useful as hemostatic compositions Relates to the composition. Also provided are methods of treating injuries and delaying or stopping bleeding using the hemostatic compositions disclosed herein. The hemostatic composition can activate the coagulation cascade or enhance binding to tissue. |